Machine could make CAR T-cell therapy more accessible
Researchers have developed a new bioreactor that can manufacture T cells faster than other technologies, which may advance immunotherapy.
List view / Grid view
Researchers have developed a new bioreactor that can manufacture T cells faster than other technologies, which may advance immunotherapy.
An epitope on CD95 receptor causes tumour cells to self-destruct and may prolong benefits of CAR T-cell therapy for solid tumours.
Scientists have developed ExoCaps, self-healing microcapsules that are more feasible than other cell-based technologies.
New research improves patient care by finding where gene copies integrate into DNA and using lentiviral vectors.
CRISPR-DREAM tool used to activate insufficiently expressed genes and convert skin cells to induced pluripotent stem cells (iPSCs).